{"id":"556038-9321","orgnr":"556038-9321","name":"Swedish Orphan Biovitrum AB (publ)","name_registered_on":"2010-05-06","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"1939-11-20","business_description":"Föremålet för bolagets verksamhet är att bedriva forskning, fabriksrörelse och handel, främst inom läkemedelsbranschen samt idka annan därmed förenlig verksamhet.","industries":[{"code":"46460","name":"Partihandel med medicinsk utrustning och apoteksvaror"},{"code":"77400","name":"Leasing av immateriell egendom och liknande produkter, med undantag för upphovsrättsskyddade verk"}],"postal_address":{"postal_code":"11276","city":"STOCKHOLM","country":"SE","municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0180","name":"Stockholm"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"8","name":"200-499 anställda"},"turnover_class":{"code":"11","name":"5 000 000 - 9 999 999 tkr","year":2025},"public_company":{"code":"21","name":"Publikt, Stockholm Large Cap"},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-01-01","to":"2024-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300124Y3MQI87PT35/2024-12-31/ESEF/SE/0/sobi-2024-12-31-sv.zip","url":"https://filings.xbrl.org/549300124Y3MQI87PT35/2024-12-31/ESEF/SE/0/sobi-2024-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2023-01-01","to":"2023-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300124Y3MQI87PT35/2023-12-31/ESEF/SE/0/sobi-2023-12-31-sv.zip","url":"https://filings.xbrl.org/549300124Y3MQI87PT35/2023-12-31/ESEF/SE/0/sobi-2023-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2022-01-01","to":"2022-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300124Y3MQI87PT35/2022-12-31/ESEF/SE/0/sobi-2022-12-31-sv.zip","url":"https://filings.xbrl.org/549300124Y3MQI87PT35/2022-12-31/ESEF/SE/0/sobi-2022-12-31-sv/reports/ixbrlviewer.html"}},{"from":"2021-01-01","to":"2021-12-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300124Y3MQI87PT35/2021-12-31/ESEF/SE/0/549300124Y3MQI87PT35-2021-12-31-sv.zip","url":"https://filings.xbrl.org/549300124Y3MQI87PT35/2021-12-31/ESEF/SE/0/549300124Y3MQI87PT35-2021-12-31-sv/reports/ixbrlviewer.html"}}],"latest_financials":{"from":"2024-01-01","to":"2024-12-31","scope":"group","currency":"SEK","net_sales":26027000000,"operating_profit":5625000000,"profit_after_financial_items":4407000000,"net_profit":3879000000,"total_assets":75444000000,"equity":40295000000,"long_term_liabilities":22549000000,"current_liabilities":12600000000,"cash":1140000000,"net_sales_growth":0.176,"source":{"annual_report":"2024-12-31","document":"https://filings.xbrl.org/549300124Y3MQI87PT35/2024-12-31/ESEF/SE/0/sobi-2024-12-31-sv/reports/ixbrlviewer.html"},"anchors":{"cash":{"fact":"f-85"},"current_liabilities":{"fact":"f-135"},"equity":{"fact":"f-105"},"long_term_liabilities":{"fact":"f-119"},"net_profit":{"fact":"f-27"},"net_sales":{"fact":"f-1"},"operating_profit":{"fact":"f-15"},"profit_after_financial_items":{"fact":"f-23"},"total_assets":{"fact":"f-89"}}}}